Lowering of blood pressure and pulse rate by switching from dpp-4 inhibitor to luseogliflozin in patients with type 2 diabetes complicated with hypertension: a multicenter, prospective, randomized, open-label, parallel-group comparison trial (luna study)

HIGHLIGHTS

• who: Reina Hashimoto-Kameda from the University, , Kita-ku, Sapporo, Japan have published the research work: Lowering of blood pressure and pulse rate by switching from DPP-4 inhibitor to luseogliflozin in patients with type 2 diabetes complicated with hypertension: A multicenter, prospective, randomized, open-label, parallel-group comparison trial (LUNA study), in the Journal: (JOURNAL)
• what: Although several studies have reported a lowering effect of SGLT2i on clinical BP, most of the studies did not focus on nighttime BP. This study investigated the significance of switching from DPP-4i to luseogliflozin on the changes . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.